Gufic Biosciences Announcements
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025 is attached herewith
06 Jan, 2026 | 07:11pm • Source: BSE
Intimation of closure of Trading Window for the quarter and nine months ended December 31, 2025 is attached herewith
30 Dec, 2025 | 04:58pm • Source: BSE
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith.
27 Dec, 2025 | 09:59pm • Source: BSE
Intimation of ESG Rating is attached herewith
10 Dec, 2025 | 05:45pm • Source: BSE
Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer Requests of Physical Shares is attached herewith
21 Nov, 2025 | 06:49pm • Source: BSE
Written Transcript of Earnings Conference Call held on November 17, 2025 at 04:30 p.m. is attached herewith.
21 Nov, 2025 | 06:40pm • Source: BSE
Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find...
17 Nov, 2025 | 07:27pm • Source: BSE
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Recording of the Earnings Conference...
17 Nov, 2025 | 07:21pm • Source: BSE
Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025 is attached herewith
14 Nov, 2025 | 07:53pm • Source: BSE
Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2025 is attached herewith.
14 Nov, 2025 | 07:18pm • Source: BSE
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we...
14 Nov, 2025 | 07:03pm • Source: BSE
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,...
11 Nov, 2025 | 06:29pm • Source: BSE
Intimation of Credit Rating is attached herewith
10 Nov, 2025 | 08:08pm • Source: BSE
Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and...
07 Nov, 2025 | 03:40pm • Source: BSE
Newspaper Advertisement regarding 100 days campaign - "Saksham Niveshek" is attached herewith.
18 Oct, 2025 | 05:45pm • Source: BSE
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025 is attached herewith
07 Oct, 2025 | 06:57pm • Source: BSE
Voting Results and Consolidated Scrutinizer Report of 41st Annual General Meeting of the Company held on Monday, September 29, 2025 is attached herewith
30 Sep, 2025 | 07:21pm • Source: BSE
Proceedings of the 41st Annual General Meeting of the Company held on Monday, September 29, 2025 is attached herewith.
29 Sep, 2025 | 07:38pm • Source: BSE
Intimation of closure of Trading Window for the quarter and half year ended September 30, 2025 is attached herewith.
26 Sep, 2025 | 07:39pm • Source: BSE
Newspaper Advertisement regarding Special Window for re-lodgement of transfer requests of physical shares is attached herewith
24 Sep, 2025 | 07:36pm • Source: BSE